The generic name for Maxalt is rizatriptan [1]. Rizatriptan is available as a tablet and a orally disintegrating tablet [1].
How does rizatriptan work?
Rizatriptan is a triptan medication that works by narrowing blood vessels in the brain. It is used to treat migraines with or without aura in adults [1].
When does patent exclusivity for rizatriptan expire?
Information on specific patent expiry dates for rizatriptan formulations can be found on DrugPatentWatch.com [2].
Who makes rizatriptan?
Rizatriptan is manufactured by several pharmaceutical companies. Brand-name Maxalt was originally developed by Merck & Co. [1]. Generic versions are now produced by various manufacturers.
What are the side effects of rizatriptan?
Common side effects of rizatriptan can include dizziness, drowsiness, fatigue, nausea, vomiting, and a tingling or numbing sensation [1]. More serious side effects, though rare, may occur.
Are there alternatives to rizatriptan for migraine treatment?
Yes, there are other triptans available for migraine treatment, such as sumatriptan, zolmitriptan, and naratriptan. Non-triptan options include over-the-counter pain relievers, CGRP inhibitors, and gepants [3].
How does rizatriptan compare to other triptans?
Different triptans have varying onset times and durations of action. The choice of triptan often depends on individual patient response and preference. Rizatriptan is known for its relatively fast onset of action [1].
What is the cost of generic rizatriptan?
The cost of generic rizatriptan can vary depending on the pharmacy, dosage, and insurance coverage. It is generally less expensive than the brand-name version [4].
What is the difference between Maxalt and Maxalt-MLT?
Maxalt comes as a regular tablet that is swallowed with water. Maxalt-MLT is an orally disintegrating tablet that dissolves on the tongue, making it a convenient option for those who have difficulty swallowing pills or experience nausea [1]. Both contain rizatriptan.
Can generic rizatriptan be used for children?
Rizatriptan is approved for the treatment of migraines in children and adolescents aged 6 to 17 years, available in both tablet and orally disintegrating tablet forms [1].
What clinical data is available for rizatriptan?
Clinical trials have demonstrated the efficacy and safety of rizatriptan in treating migraine headaches [1].
Sources:
[1] https://www.drugs.com/maxalt.html
[2] https://www.drugpatentwatch.com/
[3] https://migraineagain.com/migraine-treatments/medications/triptans/
[4] https://www.goodrx.com/rizatriptan